Canopus BioPharma Incorporated
CBIA · OTC
8/31/2022 | 8/31/2021 | 6/30/2014 | 6/30/2013 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $1 | $29 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | -$1 | $0 | $0 |
| Total Curr. Assets | $4 | $1 | $29 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $961 | $1,323 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $574 | $429 |
| Total NC Assets | $0 | $0 | $1,534 | $1,752 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4 | $1 | $1,563 | $1,752 |
| Liabilities | – | – | – | – |
| Payables | $7 | $0 | $0 | $0 |
| Short-Term Debt | $10 | $0 | $1,851 | $4,059 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $7 | $255 | $329 |
| Total Curr. Liab. | $17 | $7 | $2,106 | $4,388 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $17 | $0 | $2,106 | $4,388 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $306 | $274 |
| Retained Earnings | -$766 | -$2 | -$10,194 | -$9,668 |
| AOCI | $753 | $3 | $7,967 | $7,558 |
| Other Equity | -$1 | -$1 | $1,378 | -$800 |
| Total Equity | -$13 | $1 | -$543 | -$2,636 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4 | $1 | $1,563 | $1,752 |
| Net Debt | $6 | -$1 | $1,822 | $4,059 |